News for Orthofix Medical Inc. (OFIX)

Orthofix Medical (OFIX), a prominent name in the medical device industry, has recently received an updated analyst rating from JMP Securities. The firm has chos

On June 4, 2025, [Alan Bazaar](https://www.gurufocus.com/insider/28303/alan-bazaar), a Director at Orthofix Medical Inc (OFIX), purchased 2,250 shares of the co

On May 12, 2025, Alan Bazaar, a Director at Orthofix Medical Inc (OFIX), purchased 3,990 shares of the company. Following this transaction, the insider now owns

Pro Forma Net Sales: $189.2 million, representing a 6% year-over-year constant currency growth.US Spinal Succession Growth: 5.4% on a same sales day basis.Bone

May 06, 2025 / 12:30PM GMTOperator Thank you for standing by. My name is Tina, and I will be your conference operator today. At this time, I would like to welco

The following slide deck was published by Orthofix Medical Inc.

Orthofix Medical Inc. (NASDAQ:OFIX) Q1 2025 Earnings Conference Call May 6, 2025 8:30 AM ETCompany ParticipantsJulie Dewey - Chief Investor Relations and...

Orthofix (OFIX) has updated its financial expectations for the fiscal year 2025. The company anticipates net sales will fall between $808 million and $816 milli

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the first quarter ended March 31, 20

Revenue: Achieved $193.6 million, surpassing the estimated $191.10 million for the quarter.Earnings Per Share (EPS): Reported a loss of $(1.35) per share, sign

\nEngine Capital LP (together with its affiliates, â\u0080\u009cEngineâ\u0080\u009d or â\u0080\u009cweâ\u0080\u009d), which owns approximately one percent of the outstanding common shares of Lyft, Inc.

Orthofix Medical Inc. (OFIX) has reported a significant uptick in revenue for the first quarter of 2025, marking an 18% to 19% increase compared to the same per

[url="]Orthofix Medical Inc[/url]. (NASDAQ:OFIX), a leading global medical technology company, today announced it has received U.S. Food and Drug Administratio

NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Or

[url=

On March 5, 2025, Massimo Calafiore, President & Chief Executive Officer of Orthofix Medical Inc, purchased 9,914 shares of the company. Following this transact

Transaction Overview On February 28, 2025, Juniper Investment Company, LLC (Trades, Portfolio) made a strategic decision to reduce its holdings in Lincoln Educa

[url="]Orthofix Medical Inc[/url]. (NASDAQ:OFIX), a leading global medical technology company, today announced that the Company will participate in the 37th An

Net Sales: $215.7 million in Q4 2024, representing 8% year-over-year growth on a constant currency basis.Adjusted EBITDA: $23.9 million in Q4, with 130 basis p